On Tuesday, Shares of Pfizer Inc. (NYSE:PFE), lost -0.18% to $33.53.
Pfizer Inc., declared the election of Joseph J. Echevarria to its Board of Directors, effective right away. Mr. Echevarria also was designated to the Audit, Regulatory and Compliance and Science and Technology Committees of Pfizer’s Board.
Mr. Echevarria, 58, stepped down as Chief Executive Officer (CEO) of Deloitte LLP, a global provider of professional services, in August 2014. He had been with the firm for 36 years and served in various leadership roles, counting Deputy Managing Partner, Southeast Region Audit Managing Partner, U.S. Managing Partner and Chief Operating Officer. He was designated CEO in 2011.
Mr. Echevarria serves as a Director of The Bank of New York Mellon Corporation. He is a member of the President’s Export Council and the Presidential Commission on Election Administration and also serves as Chair of President Obama’s My Brother’s Keeper Alliance. He serves on the Board of Trustees of the University of Miami.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.
Shares of MiMedx Group, Inc. (NASDAQ:MDXG), inclined 0.17% to $11.59, during its last trading session.
MiMedx Group, declared that its Chairman and CEO, Parker H. “Pete” Petit, has been awarded the Lifetime Achievement Award in the EY Entrepreneur Of The Year® 2015 Southeast Program.
The Entrepreneur Of The Year Program, now in its 29th year, has expanded globally to recognize company builders in over 145 cities and in more than 60 countries worldwide. The program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their business and communities. The regional award recipients go on to compete for the EY Entrepreneur Of The Year National Awards which will be declared at the EY Planned Growth Forum®, the nation’s most prestigious gathering of high-growth, market-leading companies.
In addition to Pete Petit, ten other entrepreneurs were named award recipients in various industry categories in the Southeast Program. EY acknowledged Petit for his success as a serial entrepreneur, and for leading and investing personally in MiMedx at a time when the company had no revenue.
MiMedx Group, Inc. develops, processes, and markets patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. Its biomaterial platform technologies are AmnioFix, EpiFix, and CollaFix.
Finally, Goldcorp Inc. (NYSE:GG), ended its last trade with -0.98% loss, and closed at $16.20, hitting its lowest level.
Goldcorp Inc., declared the closing of the formerly declared secondary offering of the shares in Tahoe Resources Inc.. A total of 58,051,692 Tahoe common shares beneficially held by Goldcorp were sold at an offering price of C$17.20 per share for gross proceeds of about C$1 billion. The Offering was accomplished through a syndicate of underwriters led by GMP Securities L.P. and BMO Nesbitt Burns Inc. acting as joint book-runners and counting CIBC World Markets Inc., HSBC Securities (Canada) Inc., RBC Dominion Securities Inc., Scotia Capital Inc., TD Securities Inc., Citigroup Global Markets Canada Inc., Credit Suisse Securities (Canada), Inc., Goldman Sachs Canada Inc., Laurentian Bank Securities Inc., Merrill Lynch Canada Inc., Morgan Stanley Canada Ltd., Beacon Securities Limited, Canaccord Genuity Corp., Cormark Securities Inc., Dundee Securities Ltd., Macquarie Capital Markets Canada Ltd., Paradigm Capital Inc. and Raymond James Ltd.
“This transaction is consistent with our long-term commitment to maintaining a strong balance sheet,” said Chuck Jeannes, Goldcorp President and CEO. “The team at Tahoe has done an outstanding job of creating shareholder value and we wish them continued success in the future.”
As a result of the Offering, Goldcorp no longer owns any common shares of Tahoe. Tahoe did not receive any proceeds from the Offering.
Goldcorp Inc. engages in the acquisition, exploration, development, and operation of precious metal properties in Canada, the United States, Mexico, and Central and South America. The company primarily explores for gold, silver, copper, lead, and zinc deposits.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
